Serstech (SERT.ST) Stock Analysis & AI Equity Report
Serstech (SERT.ST) overview
Serstech (SERT.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Serstech reported revenue of SEK 38.6m and operating profit of SEK -28.9m; the year-end share price was 0.57 SEK and market capitalisation was SEK 145m. Serstech is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Serstech's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-27. Data will be refreshed during report generation.
About Serstech
Serstech AB develops, produces and sells products and services for molecular analysis. Its main offering is handheld Raman spectrometers and related software and substance libraries used to identify chemicals quickly in the field or in production environments. The company serves security, law enforcement, first responders and pharmaceutical customers, with operations based in Sweden.
Generate the Serstech report
Serstech is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Serstech and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.